can retatrutide cause cancer Side Effects: What Clinical Trials Tell Us Unapproved weight loss drug retatrutide

The trial, conducted across multiple international sites and involving 725 adults living with obesity or overweight but without type 2 diabetes, concluded in April 2026 after 76 weeks of treatment

Interestingly, the reduction in HbA1c was already evident after the first 4 weeks of treatment and remained statistically significant up to the end of the 52-week observation period, supporting the evidence of rapid efficacy of the drug and great durability, which was independent from weight loss

Even researchers targeting 12mg will spend their first four weeks at 1mg, making this the dose level every single protocol participant experiences

Healthy Fats: The Smooth Operators Healthy fats are like the smooth jazz of the nutrition world they make everything better without making a fuss about it

Refrigeration preserves potency and prevents peptide degradation